Catalyst Pharmaceuticals Inc (CPRX) — Financial Flexibility Index
Catalyst Pharmaceuticals Inc (CPRX) has a Financial Flexibility Index of 0.44x as of March 2026. Free cash flow of $59.61 Million (operating CF $59.59 Million minus capex $27.00K) represents 0% of total liabilities ($134.91 Million). Check cash flow reinvestment rate of Catalyst Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Catalyst Pharmaceuticals Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Catalyst Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see CPRX cash flow metrics.
Annual Financial Flexibility Index for Catalyst Pharmaceuticals Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Catalyst Pharmaceuticals Inc. Explore CPRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.37x | $208.73 Million | $208.67 Million | $152.54 Million | ▼ -29.5% |
| 2024 | 1.94x | $240.36 Million | $239.81 Million | $123.78 Million | ▼ -29.1% |
| 2023 | 2.74x | $225.34 Million | $143.60 Million | $82.23 Million | ▲ +77.6% |
| 2022 | 1.54x | $116.08 Million | $116.05 Million | $75.21 Million | ▼ -22.2% |
| 2021 | 1.98x | $61.39 Million | $60.37 Million | $30.96 Million | ▲ +0.2% |
| 2020 | 1.98x | $45.05 Million | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.63 Million | $34.61 Million | $24.75 Million | ▲ +152.8% |
| 2018 | -2.65x | $-25.61 Million | $-25.70 Million | $9.67 Million | ▲ +14.1% |
| 2017 | -3.09x | $-13.65 Million | $-13.74 Million | $4.42 Million | ▲ +58.6% |
| 2016 | -7.45x | $-17.87 Million | $-17.96 Million | $2.40 Million | ▼ -91.6% |
| 2015 | -3.89x | $-17.99 Million | $-18.02 Million | $4.63 Million | ▼ -161.6% |
| 2014 | -1.49x | $-12.88 Million | $-12.94 Million | $8.67 Million | ▲ +40.0% |
| 2013 | -2.48x | $-9.87 Million | $-9.88 Million | $3.98 Million | ▼ -5.6% |
| 2012 | -2.35x | $-5.09 Million | $-5.14 Million | $2.17 Million | ▼ -17.3% |
| 2011 | -2.00x | $-4.98 Million | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.97x | $-3.75 Million | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.04x | $-7.68 Million | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $-8.26 Million | $1.47 Million | ▲ +54.1% |
| 2007 | -12.20x | $-4.36 Million | $-4.42 Million | $357.17K | ▼ -714.9% |
| 2006 | -1.50x | $-1.16 Million | $-1.18 Million | $772.85K | ▼ -13.8% |
| 2005 | -1.32x | $-451.42K | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.37x | $-228.69K | $-230.52K | $67.80K | — |